Medtronic (NY:MDT)

94.63 +1.86 (+2.00%)

Official Closing Price Updated: 7:00 PM EDT, Oct 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

69 70 Next >

What is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill. ↗

February 08, 2026

These companies pay very healthy dividends.

Via The Motley Fool

Topics Bonds

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗

February 07, 2026

Eli Lilly is the leader in the GLP-1 space, but here's another GLP-1 stock and a medical device maker to consider.

Via The Motley Fool

The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition

February 05, 2026

In a move that has sent shockwaves through the medical technology sector, Boston Scientific (NYSE:BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra (NYSE:PEN) for...

Via MarketMinute

Topics Supply Chain

Medtronic PLC (NYSE:MDT) Shows High-Probability Technical Breakout Setup ↗

January 28, 2026

Via Chartmill

Medtronic PLC (NYSE:MDT) Stands Out as a Dependable Dividend Stock ↗

January 16, 2026

Via Chartmill

Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX)

February 05, 2026

February 5, 2026 The medical technology landscape experienced a seismic shift this week as one of its long-standing titans, Boston Scientific (NYSE: BSX), faced a "valuation reset" that has left...

Via Finterra

Topics Product Recall World Trade

Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors ↗

February 04, 2026

Today, Feb. 4, 2026, investors are weighing Boston Scientific’s guidance against new deals and its long-term margin path.

Via The Motley Fool

Topics Earnings Stocks

2 Healthcare Dividend Stocks That are Just What the Doctor Ordered ↗

February 03, 2026

AbbVie and Medtronic have a long history of raising their dividends and continue to have healthy free cash flow for further dividend growth.

Via The Motley Fool

Topics Intellectual Property

Medtronic Bets On AI Heart Care With $585 Million Deal For Partner CathWorks ↗

February 03, 2026

Medtronic plans to acquire heart imaging firm CathWorks for up to $585 million, expanding its digital heart care tools as the deal awaits U.S. regulatory approval.

Via Benzinga

Topics Artificial Intelligence

Boston Scientific’s $14.5 Billion Stroke of Genius: Consolidation Heats Up in the Medtech Arms Race

February 02, 2026

In a move that has sent shockwaves through the healthcare sector, Boston Scientific (NYSE:BSX) has announced a definitive agreement to acquire Penumbra (NYSE:PEN) for approximately $14.5 billion. The...

Via MarketMinute

Topics Artificial Intelligence

Are Wall Street Analysts Predicting Medtronic Stock Will Climb or Sink?

February 02, 2026

Although Medtronic has lagged behind the S&P 500 Index over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Via Barchart.com

Topics ETFs Stocks

2 AI Surgery Stocks to Buy Hand Over Fist in February ↗

January 30, 2026

Artificial intelligence isn't performing surgery yet, but if (when?) it does, these two companies are likely to be at the heart of it.

Via The Motley Fool

Topics Artificial Intelligence

Foundation for the AI Era: Texas Instruments Commences Volume Production at $60 Billion SM1 ‘Mega-Fab’ in Sherman, Texas

January 30, 2026

In a landmark moment for the American semiconductor industry, Texas Instruments (NASDAQ: TXN) has officially commenced volume production at its state-of-the-art SM1 fab in Sherman, Texas. The facility,...

Via TokenRing AI

Topics Artificial Intelligence Economy Supply Chain

Boston Scientific to Acquire Penumbra for $14.5 Billion in Massive MedTech Consolidation

January 28, 2026

MARLBOROUGH, Mass. — In a move that has sent shockwaves through the medical technology landscape, Boston Scientific (NYSE: BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra...

Via MarketMinute

The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants

January 27, 2026

In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced on January 15, 2026, its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN)...

Via MarketMinute

Caterpillar, Medtronic, Transocean And A Financial Stock: CNBC's 'Final Trades' ↗

January 26, 2026

CNBC's Halftime Report: Bryn Talkington sticking with Capital One (COF) expecting it to rise to $250 in a year. Kevin Simpson chooses Medtronic (MDT).

Via Benzinga

Johnson & Johnson 2026 Outlook: Chasing the $100 Billion Milestone Amidst Legal and Patent Hurdles

January 23, 2026

Following a resilient performance throughout 2025, healthcare giant Johnson & Johnson (NYSE: JNJ) has officially set its sights on a historic milestone for 2026. In its latest earnings report released...

Via MarketMinute

Topics Artificial Intelligence Bankruptcy Economy

Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026

January 23, 2026

As of January 23, 2026, Johnson & Johnson (NYSE:JNJ) finds itself at a historic crossroads. After spending much of 2025 navigating the "patent cliff" of its blockbuster drug Stelara and finalizing its...

Via MarketMinute

Topics Artificial Intelligence Bankruptcy Economy

Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises

January 22, 2026

From Anteris Technologies Global Corp.

Via GlobeNewswire

Resilience in the Face of the Patent Cliff: Johnson & Johnson Forecasts Landmark 2026 Growth

January 22, 2026

NEW BRUNSWICK, N.J. – Johnson & Johnson (NYSE: JNJ) has signaled a definitive turning point in its corporate evolution, issuing a robust 2026 financial outlook that defies the gravity of the...

Via MarketMinute

Topics Earnings Economy Intellectual Property

Abbott Shares Slump as Revenue Miss and Exact Sciences Acquisition Jitters Overshadow Earnings Beat

January 22, 2026

Abbott Laboratories (NYSE: ABT) saw its shares retreat by 5.8% in early trading on Thursday, January 22, 2026, following the release of its fourth-quarter financial results. Despite delivering an...

Via MarketMinute

Topics Earnings Economy

What to Expect From Medtronic's Next Quarterly Earnings Report

January 22, 2026

Medtronic is expected to announce its fiscal third-quarter earnings next month, and analysts project a single-digit profit drop.

Via Barchart.com

Topics ETFs

Want Decades of Passive Income? 2 Stocks to Buy Right Now. ↗

January 22, 2026

Their dividend streaks speak volumes.

Via The Motley Fool

Topics Artificial Intelligence

Where Will Intuitive Surgical Be in 5 Years? ↗

January 21, 2026

The bullish case for the stock remains strong.

Via The Motley Fool

J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll ↗

January 21, 2026

The company is an expert in electrophysiology, but two key rivals are making a dent in its sales.

Via Investor's Business Daily

Topics Stocks

Why Did AVR Stock Surge Pre-Market Today? ↗

January 21, 2026

The company unveiled a $200 million dilution alongside a $90 million investment from healthcare technology heavyweight Medtronic.

Via Stocktwits

Nasdaq, S&P 500 Futures Rebound, All Eyes On Trump’s Davos Speech: Why TSLA, NVDA, NFLX, AVR Are On Traders' Radar Today ↗

January 21, 2026

Retail sentiment on Stocktwits on SPY and QQQ turned ‘extremely bearish’.

Via Stocktwits

Topics Artificial Intelligence ETFs Economy

The Titan’s Balance: Johnson & Johnson Reaches Record Highs Amidst Legal Hurdles and Med-Tech Transformation

January 20, 2026

As the healthcare industry looks toward 2026, Johnson & Johnson (NYSE: JNJ) stands at a historic crossroads, reinforcing its reputation as the ultimate bellwether for the global healthcare sector. On...

Via MarketMinute

Topics Bankruptcy Lawsuit World Trade

3 Reasons to Add This Medical Technology Stock to Your Portfolio in 2026 ↗

January 18, 2026

The future is looking brighter for this healthcare giant.

Via The Motley Fool

Topics World Trade

"Animal Spirits" Return: Morgan Stanley Signals M&A Renaissance as Healthcare and Industrials Lead Shifting Landscape

January 15, 2026

As 2026 begins, the global mergers and acquisitions (M&A) market is witnessing a profound "renaissance," driven by a confluence of stabilizing interest rates, record levels of corporate cash, and a...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

69 70 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.